SynthesisFrontiers in oncology2021

Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Xu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.